oxybutynin chloride extended release

Generic: oxybutynin chloride

Labeler: lannett company, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oxybutynin chloride extended release
Generic Name oxybutynin chloride
Labeler lannett company, inc.
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

oxybutynin chloride 5 mg/1

Manufacturer
Lannett Company, Inc.

Identifiers & Regulatory

Product NDC 62175-270
Product ID 62175-270_72bbc7a8-711b-47a6-8152-9409f4068929
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078503
Listing Expiration 2026-12-31
Marketing Start 2009-03-01

Pharmacologic Class

Classes
cholinergic muscarinic antagonist [epc] cholinergic muscarinic antagonists [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62175270
Hyphenated Format 62175-270

Supplemental Identifiers

RxCUI
863619 863628 863636
UNII
L9F3D9RENQ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oxybutynin chloride extended release (source: ndc)
Generic Name oxybutynin chloride (source: ndc)
Application Number ANDA078503 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-37)
  • 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-41)
source: ndc

Packages (2)

62175-270-37 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-37) 62175-270-41 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-41)

Ingredients (1)

oxybutynin chloride (5 mg/1)

Linked Drug Pages (1)

Oxybutynin Chloride Extended Release ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "72bbc7a8-711b-47a6-8152-9409f4068929", "openfda": {"unii": ["L9F3D9RENQ"], "rxcui": ["863619", "863628", "863636"], "spl_set_id": ["c5950dba-d92b-46a0-993f-af9f9ddb52bf"], "manufacturer_name": ["Lannett Company, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-37)", "package_ndc": "62175-270-37", "marketing_start_date": "20090301"}, {"sample": false, "description": "500 TABLET, EXTENDED RELEASE in 1 BOTTLE (62175-270-41)", "package_ndc": "62175-270-41", "marketing_start_date": "20090301"}], "brand_name": "Oxybutynin Chloride Extended Release", "product_id": "62175-270_72bbc7a8-711b-47a6-8152-9409f4068929", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cholinergic Muscarinic Antagonist [EPC]", "Cholinergic Muscarinic Antagonists [MoA]"], "product_ndc": "62175-270", "generic_name": "Oxybutynin Chloride", "labeler_name": "Lannett Company, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Oxybutynin Chloride", "brand_name_suffix": "Extended Release", "active_ingredients": [{"name": "OXYBUTYNIN CHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA078503", "marketing_category": "ANDA", "marketing_start_date": "20090301", "listing_expiration_date": "20261231"}